SCHEMBL6657084

SCHEMBL6657084

CC#CCOc1ccc(Sc2cc(OCC)ccc2CC(=O)O)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP9 P14780 5/20 0.44
MMP2 P08253 2/20 0.44
MMP12 P39900 1/20 0.44
ADAM17 P78536 7/20 0.42
CYP2C9 P11712 1/20 0.41
HPGD P15428 1/20 0.41
CYP2C19 P33261 1/20 0.41
MMP13 P45452 4/20 0.40
MMP1 P03956 2/20 0.36
ALDH1A1 P00352 2/20 0.36
LMNA P02545 1/20 0.36
MAPK1 P28482 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
MAPT P10636 1/20 0.36
AGBL2 Q5U5Z8 1/20 0.36
SQSTM1 Q13501 1/20 0.36
KEAP1 Q14145 1/20 0.36
NFE2L2 Q16236 1/20 0.36
PPARA Q07869 1/20 0.36
MMP14 P50281 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6659000 0.90 MMP9 (0.53) MMP9MMP2MMP12ADAM17CYP2C9
SCHEMBL6660771 0.87 MMP9 (0.44) MMP9MMP2MMP12ADAM17CYP2C9
SCHEMBL6657572 0.84 MMP9 (0.62) MMP9MMP2MMP12ADAM17CYP2C9
SCHEMBL6657407 0.81 MMP9 (0.46) MMP9MMP2MMP12ADAM17CYP2C9
SCHEMBL11351435 0.80 AGBL2 (0.53) MMP9MMP2MMP12CYP2C9HPGD
SCHEMBL6656710 0.80 PTGS2 (0.42) MMP9MMP2ADAM17MMP13MMP1
SCHEMBL6656390 0.76 ADAM17 (0.44) MMP9MMP2MMP12ADAM17CYP2C9
SCHEMBL6654463 0.76 ADAM17 (0.47) MMP9MMP2MMP12ADAM17CYP2C9
SCHEMBL6655627 0.75 ADAM17 (0.40) MMP9MMP2MMP12ADAM17MMP13
SCHEMBL8231076 0.72 MMP9 (0.65) MMP9MMP2MMP12ADAM17CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1147080-B1 ALKYNYL CONTAINING HYDROXAMIC ACID COMPOUNDS AS TACE INHIBITORS WYETH CORP (US) 2004-07-21 EP disclosed
US-6340691-B1 TREATMENT OF ARTHRITIS, TUMOR METASTASIS, TISSUE ULCERATION, ABNORMAL WOUND HEALING, PERIODONTAL DISEASE, BONE DISEASE, DIABETES (INSULIN RESISTANCE) AND HIV INFECTION AMERICAN CYANAMID COMPANY 2002-01-22 US disclosed
EP-1147080-A1 ALKYNYL CONTAINING HYDROXAMIC ACID COMPOUNDS AS TACE INHIBITORS American Cyanamid Company (US) 2001-10-24 EP disclosed
WO-2000044713-A1 ALKYNYL CONTAINING HYDROXAMIC ACID COMPOUNDS AS TACE INHIBITORS AMERICAN CYANAMID COMPANY (US) 2000-08-03 WO disclosed